William Resides
Chief Executive Officer at FINDIT
Net worth: 930 335 $ as of 2024-04-29
William Resides active positions
Companies | Position | Start | End |
---|---|---|---|
FINDIT | Director/Board Member | 2024-03-07 | - |
Chief Executive Officer | 2024-03-07 | - |
Career history of William Resides
Former positions of William Resides
Companies | Position | Start | End |
---|---|---|---|
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Chief Executive Officer | 2019-01-01 | - |
Founder | 2019-01-01 | - | |
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - |
Statistics
International
United States | 4 |
Operational
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Founder | 2 |
Sectoral
Health Technology | 2 |
Technology Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
FINDIT | Technology Services |
Private companies | 2 |
---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
- Stock Market
- Insiders
- William Resides
- Experience